BSW Wealth Partners’s Omnicell OMCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-9,015
Closed -$529K 306
2023
Q1
$529K Buy
9,015
+275
+3% +$15.2K 0.11% 130
2022
Q4
$441K Buy
8,740
+4,103
+88% +$246K 0.09% 152
2022
Q3
$404K Buy
4,637
+199
+4% +$20.9K 0.1% 139
2022
Q2
$505K Buy
4,438
+939
+27% +$108K 0.12% 116
2022
Q1
$453K Buy
3,499
+438
+14% +$63.1K 0.11% 137
2021
Q4
$552K Buy
3,061
+187
+7% +$32.4K 0.14% 105
2021
Q3
$427K Buy
2,874
+318
+12% +$48.7K 0.12% 119
2021
Q2
$387K Buy
2,556
+704
+38% +$98K 0.11% 127
2021
Q1
$241K Buy
+1,852
New +$238K 0.07% 182

Other funds holding OMCL

BSW Wealth Partners's OMCL Position: Q2 2023 in Review

BSW Wealth Partners sold out of Omnicell (OMCL) in Q2 2023, closing a stake of 9,015 shares — an estimated $529K sold.

BSW Wealth Partners first reported a position in OMCL in Q1 2021 and held it in 9 quarters. The position peaked at $552K in Q4 2021. 313 funds tracked by Wall St. Rank hold OMCL as of Q2 2023.

  • BSW Wealth Partners reported no remaining Omnicell position as of Q2 2023 after selling out during the quarter.
  • BSW Wealth Partners sold 9,015 Omnicell shares in Q2 2023, an estimated $529K.
  • BSW Wealth Partners first reported a position in Omnicell in Q1 2021 and held it in 9 quarters.
  • BSW Wealth Partners's Omnicell position peaked at $552K in Q4 2021.
  • 313 funds tracked by Wall St. Rank held Omnicell as of Q2 2023.

Based on BSW Wealth Partners's 13F filing for Q2 2023, filed 11 Aug 2023.